Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-05-21

Clinical Trial Update: A Study of Contrast-Enhanced Mammography (CEM) Scans in People With Breast Cancer

View source ↗

Summary

A clinical trial evaluating contrast-enhanced mammography in people with breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Status: WITHDRAWN